New operating models will bring much-needed agility

Pharmaceutical Industry Trends - New operating models will bring much-needed agility

Pharmaceutical Industry Trends

The pharmaceutical industry is beginning to recognise the importance of agility in its operating models. New trends are emerging that focus on creating more robust and adaptive systems to drive progress and innovation. This paradigm shift to more advanced ways of developing drugs was long overdue, but there is no question that these innovative ways of working bring many benefits compared to the old approaches. 

Some of these advantages are quicker decision-making, fast integration with other organizations, better scalability and flexibility, better visibility of supply chain operations, and more effective customer service. All of these can help pharmaceutical companies remain competitive in a constantly changing market environment. Furthermore, pharmaceutical companies can benefit from using agile approaches, thereby reducing development-related costs and achieving maximum returns on their investments. 

It is an important time for the pharmaceutical industry, and agility is increasingly important. With the adoption of these new trends and technologies by pharmaceutical companies, there will be many advantages that can be taken advantage of in the future. 

The industry’s transformation heavily relies on new capacities and talent. This trend is likely to cause talent distribution, making manufacturing more flexible. For instance, the requirements to work on-site may become less acute. The workforce of post-COVID-19 times will be much more resistant to change, which may result in better distribution of organizations. 

The increasing need is for people with talent to be able to write, control, and interpret information in line with developments in technology. This process will also create up-skilling and integrated capacity-building while helping employees stay responsive to changes. 

As shown in the chart above, look at some of the major pharma trends for 2022, where agility and reorganisation are topping the charts.

In the McKinsey & Company survey, more than 80% of the US pharma companies’ executives believe that companies will largely rely on agile working methods in the near future. This suggests that organisations may simplify their structures and rely on sales representatives less often.